This book explores the ongoing transition of China's economy by examining how its healthcare industry is growing and changing. The coronavirus pandemic has reinforced one of the authors' key points: in our complex, fragile, and interconnected societies, the production of health is a vital strategic 'industry'. The case of China is particularly salient, because of its economic and geopolitical significance, and the scale of the healthcare challenge it has faced.

Adopting a multi-level perspective, the authors examine the entrepreneurial role of the Chinese government as it seeks to strengthen the competitiveness of domestic firms. They analyze the strategies employed to improve China's technology and capacity for innovation, and discuss China's strategies and policies to ensure knowledge acquisition and creation in the long-term, with particular reference to international scientific collaborations. This book is a must-read for students, researchers, and policymakers interested in the prospects and challenges posed by the growth of the Chinese healthcare industry and its global impact.

Offers a comprehensive view of the world and Chinese industry and market, from internal transformation to international exposure of Chinese firms including the corresponding impact on a global level Provides guidelines and policy proposals to support policy makers in the West and in China, as well as operational suggestions for companies working in or with China, to enhance bilateral trade and investment flows Explores the key drivers of growth and the long term transition of the health industry Highlights the main prospects and challenges that the growth of the Chinese healthcare sector poses to the rest of the world

Autorentext
Marco R. Di Tommaso is Full Professor of Applied Economic Studies, University of Ferrara, Italy, and Director of c.MET05 - The National University Centre for Applied Economic Studies, Italy. He is also a Life Member Fellow at Clare Hall, University of Cambridge, UK, and Honorary Professor at the South China University of Technology and the South China Normal University. Francesca Spigarelli is Associate Professor of Applied Economic Studies at the University of Macerata, Italy, where she is Director of the China Center, and Vice Rector for Entrepreneurship and Technological Transfer and for European Research Policy. She is also a member of the c.MET05 Steering Board. Elisa Barbieri is Associate Professor of Applied Economic Studies at the Ca' Foscari University of Venice, Italy; Senior Researcher and a member of the Steering Board at c.MET05. She is Associate Editor for the journals Competition and Change and l'Industria. Lauretta Rubini is Associate Professor of Applied Economic Studies and Coordinator of the Master's Degree Programmes at the Department of Economics and Management of the University of Ferrara, Italy. She is also Visiting Scholar at the University of California Los Angeles, USA, and Senior Researcher and a member of the Steering Board at c.MET05.

Inhalt

1. On Health Production and Demand. And why an effective Health Industry is vital for China (and the rest of the world) .- 2. The rise of China as a global player in the healthcare industry .- 3. Government planning and policy for health industry .- 4. The globalization of the industry: Chinese inward and outward FDIs .- 5. Innovation and research excellence: China in the International scientific scenario .- 6. Challenges for the future and the role of Industrial Policy.